SCHEMBL3365759

SCHEMBL3365759

C=CCN(C)CCCCCCOc1ccc(N(C)C(=O)c2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LSS P48449 15/20 0.64
MAOB P27338 2/20 0.57
GAA P10253 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3365379 0.91 LSS (0.64) LSSMEN1KMT2A
SCHEMBL3364637 0.91 LSS (0.64) LSSMEN1KMT2A
SCHEMBL3365325 0.90 LSS (0.78) LSSMEN1KMT2A
SCHEMBL3363133 0.90 LSS (0.78) LSSMEN1KMT2A
SCHEMBL3365279 0.90 LSS (0.63) LSSMEN1KMT2A
SCHEMBL3366763 0.90 LSS (0.76) LSSMEN1KMT2A
SCHEMBL3368382 0.89 LSS (0.59) LSSMAOBGAAMEN1KMT2A
SCHEMBL3368467 0.88 LSS (0.61) LSSMEN1KMT2A
SCHEMBL3366804 0.87 LSS (0.57) LSSMAOBGAAMEN1KMT2A
SCHEMBL3365180 0.87 LSS (0.80) LSSGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303503-B1 ANILINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-01-27 EP disclosed
US-6683201-B2 FOR THERAPY AND PROPHYLAXIS OF HYPERCHOLESTEROLEMIA, HYPERLIPEMIA, ARTERIOSCLEROSIS, VASCULAR DISEASES, MYCOSES, PARASITE INFECTIONS, GALLSTONES, TUMORS AND/OR HYPERPROLIFERATIVE DISORDERS, DIABETES HOFFMANN-LA ROCHE INC. 2004-01-27 US disclosed
EP-1303503-A2 ANILINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002006189-A2 ANILINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 WO disclosed